Tag: nuclear medicine diagnostics market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Nuclear Medicine Diagnostics Market?

In recent times, the market size for nuclear medicine diagnostics has experienced rapid expansion. Anticipated growth forecasts suggest an increase from $7.16 billion in 2024 to $7.94 billion in 2025, representing a compound annual growth rate (CAGR) of 11.0%. This substantial increase during the historic period is a result of factors such as advancements in the field of medical imaging, a rise in chronic diseases, an aging demographic pattern, oncology-related clinical applications, as well as the precision and accuracy of diagnostics.

What Growth Rate Is Forecasted for the Nuclear Medicine Diagnostics Market by 2029?

The market for nuclear medicine diagnostics is projected to experience swift expansion in the coming years, growing at a compound annual growth rate (CAGR) of 12.1% to reach $12.56 billion in 2029. This anticipated growth over the forecast period can be linked to the increasing utilization in neurology, amalgamation with other imaging techniques, the rising popularity of precision medicine methods, the heightened demand for theranostics, and worldwide initiatives toward disease elimination. Key trends expected in the forecast period encompass a shift towards compact, local radiopharmacy, the usage of nuclear medicine in neurology, radiomics and analytical imaging, partnerships aimed at research and development, with an increased focus on radiation safety and dosimetry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

Which Key Companies Are Shaping the Future of the Nuclear Medicine Diagnostics Market?

Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

Which Factors Are Driving Demand in the Nuclear Medicine Diagnostics Industry?

The mounting need for nuclear medicine diagnostics is anticipated to fuel the expansion of the nuclear medicine diagnostics market in the future. Nuclear medicine employs radioactive substances within the body for disease diagnoses or to target and eliminate diseased or damaged organs and tissue for treatment. The diagnostic applications of nuclear medicine are predominantly in radiation and other lethal treatments. The escalating demand for nuclear medicine diagnostics is due to benefits like precise results and improved treatment decision making. For instance, in April 2022, a report by the World Nuclear Association, an international organization promoting nuclear power based in the UK, specified that the yearly number of nuclear medicine treatments surpasses 40 million, and the requirement for radioisotopes is growing at a pace of up to 5% annually. Moreover, 90% of procedures employing radioisotopes in medicine occur in over 10,000 hospitals worldwide. Hence, the burgeoning demand for nuclear medicine diagnostics is set to boost the growth of the nuclear medicine diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9415&type=smp

How Is the Nuclear Medicine Diagnostics Market Segmented by Several Divisions?

The nuclear medicine diagnostics market covered in this report is segmented –

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

What are the Emerging Market Trends Driving the Growth of the Nuclear Medicine Diagnostics Industry?

Prime corporations within the nuclear medicine diagnostics market are strategizing to introduce superior solutions, such as avant-garde medical technologies, to create a niche in the market. These innovative medical technologies represent the pinnacle of advancements in the medical field aimed at refining patient outcomes, elevating care standards, and endorsing enhanced health. As an example, Gleneagles Hospital, a company based in Malaysia offering medical and healthcare services, unveiled its Nuclear Medicine Unit in August 2023. This nuclear medicine unit is a tailor-made facility situated within a hospital or medical center that is armed with the most recent technology and manned by highly proficient professionals. The mission of this facility is to offer early detection, diagnosis, and curative treatment of diseases through nuclear medicine imaging techniques.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Which Regions Are Driving Growth in the Nuclear Medicine Diagnostics Market?

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415

This Report Delivers Insight On:

1. How big is the nuclear medicine diagnostics market, and how is it changing globally?

2. Who are the major companies in the nuclear medicine diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the nuclear medicine diagnostics market right now?

4. Which products or customer segments are growing the most in the nuclear medicine diagnostics market?

5. What factors are helping or slowing down the growth of the nuclear medicine diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the nuclear medicine diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Nuclear Medicine Diagnostics Market, and What Factors Will Drive It?#_x000D_

In the past few years, the nuclear medicine diagnostics market has experienced fast-paced growth. The market is predicted to increase from $7.16 billion in 2024 to $7.94 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.0%. This past growth has been driven by enhancements in medical imaging technology, a rise in chronic diseases, trends in an aging population, the use of clinical applications in oncology, and an increase in diagnostic accuracy and precision._x000D_

_x000D_

In the upcoming years, the nuclear medicine diagnostics market is anticipated to experience quick expansion, inflating to a size of $12.56 billion by 2029 with a compound annual growth rate (CAGR) of 12.1%. This projected growth can be credited to the broadening application of this field in neurology, amalgamation with other imaging methods, precision medicine strategies, increased requirement for theranostics and worldwide endeavors in disease removal. Significant trends for the prediction period comprise transitions towards small-scale, decentralized radiopharmacy, the application of nuclear medicine in neurology, radiomics, and quantitative imaging examination, partnerships for research and development, and focus on radiation safety and dosimetry._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Nuclear Medicine Diagnostics Market?#_x000D_

The escalating need for nuclear medicine diagnostics is anticipated to spur the expansion of the corresponding market in the future. Nuclear medicine employs radioactive substances within the body to not only identify diseases but also pinpoint and eradicate unhealthy or impaired organs and tissue as part of the treatment regimen. Its diagnostic utility lies chiefly in radiation treatments and other procedures with serious health implications. Its popularity stems from its precise readings and improving the quality of treatment decisions. A case in point is the World Nuclear Association’s April 2022 report on nuclear medicine diagnostics which revealed that more than 40 million nuclear medicine treatments are undertaken annually, and the demand for radioisotopes grows by as much as 5% each year. Additionally, over 10,000 hospitals around the globe carry out 90% of medical processes involving radioisotopes. Therefore, it’s projected that the rising demand for nuclear medicine diagnostics will fuel the growth of its market._x000D_

_x000D_

#How Is the Nuclear Medicine Diagnostics Market Segmented?#_x000D_

The nuclear medicine diagnostics market covered in this report is segmented –_x000D_

_x000D_

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals_x000D_

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications_x000D_

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals_x000D_

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9415&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Nuclear Medicine Diagnostics Market Growth?#_x000D_

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Nuclear Medicine Diagnostics Market?#_x000D_

Leading corporations operating in the nuclear medicine diagnostics market are strategizing towards the roll-out of state-of-the-art solutions, such as advanced medical technologies, to consolidate their market position. These advanced medical technologies represent the pinnacle of medical advancements, aimed at improving patient results, uplifting the standard of patient care, and fostering improved health. For example, Gleneagles Hospital, a company based in Malaysia offering medical and healthcare services, established the Nuclear Medicine Unit in August 2023. This specialized unit within a healthcare facility or hospital comes equipped with the latest technology, supported by a team of highly adept professionals. The unit’s main objective is to offer early detection, diagnosis, and treatment of illnesses, leveraging nuclear medicine imaging techniques._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report_x000D_

_x000D_

#How Is the Nuclear Medicine Diagnostics Market Defined and What Are Its Core Parameters?#_x000D_

Nuclear medicine uses radioactive substances inside the body to diagnose illnesses or to target and remove diseased or damaged organs and tissue (for treatment). Nuclear medicine includes the use of radioactive drugs for research, therapeutic, and diagnostic purposes. Radioactive tracers are used in diagnostic nuclear medicine to visualize and/or measure the overall or local function of an organ._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Nuclear Medicine Diagnostics Market?

The escalating demand for diagnostics in the field of nuclear medicine is anticipated to spur the growth of the nuclear medicine diagnostics market. Nuclear medicine employs radioactive materials within the body for the diagnosis of ailments or for targeting and eliminating sick or damaged organs and tissue (for therapeutic reasons). The diagnostic applications of nuclear medicine center predominantly around radiation and other lethal treatments. The popularity of nuclear medicine diagnostics is on the rise due to its benefits like precision in results and improved decision making in treating patients. As an illustration, a report by the UK-based World Nuclear Association advocating for nuclear power published in April 2022 stated that the annual treatments in nuclear medicine exceed 40 million, and the requirement for radioisotopes is growing at a rate of up to 5% annually. Moreover, it stated that 90% of the medical procedures involving radioisotopes happen in more than 10,000 hospitals globally. Therefore, the growing demand for nuclear medicine diagnostics is projected to boost the nuclear medicine diagnostics market’s expansion.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

#How Does the ProjectedNuclear Medicine Diagnostics Market Growth Compare Over the Forecast Period?

The market size of nuclear medicine diagnostics has experienced significant growth lately. It is projected to escalate from $7.16 billion in 2024 to $7.94 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. The historical growth can be credited to the progression in medical imaging, rising occurrence of chronic disorders, trends of an aging populace, application in cancer treatment, and high levels of diagnostic precision and accuracy.

Anticipated to witness significant growth in the forthcoming years, the nuclear medicine diagnostics market is set to expand to a value of $12.56 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.1%. The projected growth throughout the forecasted span can be associated with factors such as an increase in uses within the field of neurology, the integration with different imaging modalities, the application of precision medicine, a rising demand for theranostics, and worldwide initiatives towards disease elimination. Foreseen trends for the forecast period encompass a shift toward decentralized, small-scale radiopharmacy, the application of nuclear medicine in neurology, the use of radiomics and quantitative imaging for analysis, partnerships for research and development, with a focal point on radiation safety and dosimetry.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415

What Are the Most Significant Market Trends Transforming theNuclear Medicine Diagnostics Market?

Leading corporations in the nuclear medicine diagnostics market are focusing on groundbreaking innovations, like state-of-the-art medical technologies, to gain a strategic advantage. These modern technologies in the medical sector aim to improve patient results, lift the care standard, and champion better health. For instance, Malaysia’s Gleneagles Hospital, a company offering medical and health care services, unveiled the Nuclear Medicine Unit in August 2023. This unit is a dedicated section within a hospital or medical institution, equipped with the most recent technology and operated by highly trained experts. The facility is created to enable early detection, diagnosis, and disease treatment using nuclear medicine imaging methods.

What Are the Top Market Players Propelling the Growth of theNuclear Medicine Diagnostics Industry?

Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Which Primary Segments of the Nuclear Medicine Diagnostics Market Are Driving Growth and Industry Transformations?

The nuclear medicine diagnostics market covered in this report is segmented –

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9415&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Nuclear Medicine Diagnostics Market?# Market?

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Nuclear Medicine Diagnostics Market 2025, By The Business Research Company:

Floating Power Plant Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/floating-power-plant-global-market-report

Solar Energy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solar-energy-global-market-report

Biomass Electricity Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biomass-electricity-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the nuclear medicine diagnostics market grown in recent years?

The market size for nuclear medicine diagnostics has seen rapid growth in the recent past. Its progression from $7.16 billion in 2024 to an estimated $7.94 billion in 2025, displaying a Compound Annual Growth Rate (CAGR) of 11.0%, demonstrates this growth. Factors such as advancements in medical imaging, a higher incidence of chronic diseases, an aging population, applications in oncology, and improved diagnostic accuracy and precision have all contributed to this growth in the historic period.

How is the nuclear medicine diagnostics market size expected to evolve during the forecast period?

Get your nuclear medicine diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Which key drivers are propelling the nuclear medicine diagnostics market’s growth?

The growth of the nuclear medicine diagnostics market is set to be driven by the rising demand for nuclear medicine diagnostics. Utilizing radioactive substances within the body, nuclear medicine diagnoses diseases or has the capability to target and remove affected organs and tissue. Primarily, the diagnostic applications of nuclear medicine are used in radiation and other serious treatments. The appealing benefits of accurate results and improved treatment decision-making processes are driving increased demand for nuclear medicine diagnostics. For example, a World Nuclear Association report released in April 2022 estimated that the annual number of nuclear medicine procedures exceeds 40 million, with the demand for radioisotopes growing by as much as 5% annually. Moreover, of the procedures involving radioisotopes in medicine, 90% are performed in over 10,000 hospitals around the globe. Thus, as the demand for nuclear medicine diagnostics grows, so too is the nuclear medicine diagnostics market projected to expand.

What are the market segments in the nuclear medicine diagnostics industry?

The nuclear medicine diagnostics market covered in this report is segmented –

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

Which leading companies are shaping the growth of the nuclear medicine diagnostics market?

Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

What key trends are currently impacting the nuclear medicine diagnostics market’s development?

The nuclear medicine diagnostics market is predominantly operated by significant corporations such as Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., and Mallinckrodt Pharmaceuticals. Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, and Curium SAS are among others. Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, and Telix Pharmaceuticals Limited also have a strong presence in the market. With others like Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., and PharmaLogic Holdings Corp dominating the landscape. Lastly, the market also involves an array of companies such as Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., and Eczacıbaşı-Monrol Nuclear Products Co.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415

Which geographic areas are influencing the growth of the nuclear medicine diagnostics market?

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Analyzing the Growth Rate of the Nuclear Fusion Market: What’s the Expected CAGR for the Next Decade?

The market size of nuclear medicine diagnostics has seen considerable growth in the past few years. It is expected to expand from $7.16 billion in 2024 to $7.94 billion in 2025, boasting an impressive compound annual growth rate (CAGR) of 11.0%. Factors contributing to this historical growth comprise advancements in medical imaging technologies, rising incidences of chronic diseases, growing age-related population trends, its clinical uses in cancer diagnosis and treatment, along with its diagnostic accuracy and precision.

The market size of nuclear medicine diagnostics is predicted to undergo swift expansion in the coming years, escalating to $12.56 billion in 2029 with a 12.1% compound annual growth rate (CAGR). This anticipated growth during the forecast period can be ascribed to its widening applications in neurology, amalgamation with other imaging methods, adoption of precision medicine techniques, increased demand for theranostics, and global initiatives towards disease eradication. The forecast period also anticipates the emergence of trends such as the shift towards decentralized, small-scale radiopharmacy, utilization of nuclear medicine in neurology, advancements in radiomics and quantitative imaging analysis, partnerships for research and development, and emphasis on radiations safety and dosimetry.

Which Major Market Drivers Are Expected to Boost the Market’s Growth Potential?

The escalating need for nuclear medicinal diagnostic techniques is anticipated to boost the expansion of the nuclear medicine diagnostics market in the future. Nuclear medicine, which operates by introducing radioactive substances into the body, can identify diseases or target and eliminate ailing or damaged organs and tissues for treatment purposes. This diagnostic method is predominantly used in radiation therapies and other life-threatening treatments. The growing need for nuclear medicine diagnostics is driven by its advantages such as precise outcomes and improved decision making regarding treatment. For example, a report released by the UK-based World Nuclear Association on nuclear medicinal diagnostics in April 2022 revealed that over 40 million nuclear medicinal treatments are administered annually and the demand for radioisotopes is growing at a rate of up to 5% each year. Furthermore, radioisotopes are used in 90% of the procedures performed in more than 10,000 hospitals around the globe. Consequently, the rising need for nuclear medicinal diagnostics is anticipated to hasten the expansion of the nuclear medicine diagnostics market.

Explore Comprehensive Insights Into The Global Nuclear Fusion Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

What Are the Leading Organizations Impacting the Nuclear Fusion Market’s Growth?

Major companies operating in the nuclear medicine diagnostics market include:

• Siemens AG_x000D_

• Bayer Aktiengesellschaft_x000D_

• Novartis AG_x000D_

• GE Healthcare Technologies Inc._x000D_

• Perkin Elmer Inc._x000D_

What Are the Most Prominent Trends Driving Change in the Nuclear Fusion Market?

Significant firms in the nuclear medicine diagnostics market are strategically introducing groundbreaking solutions such as high-end medical technologies to gain the upper hand. These medical innovations are at the forefront of the medical field, aiming to elevate patient outcomes, raise the quality of care, and enhance overall health. For instance, Gleneagles Hospital, stationed in Malaysia and renowned for their healthcare services, unveiled the Nuclear Medicine Unit in August 2023. This dedicated facility, armed with state-of-the-art technology and manned by adept professionals, is an integral part of a hospital or medical center. It seeks to provide early detection, diagnosis, and medical treatment of diseases by harnessing the power of nuclear medicine imaging techniques.

Secure Your Global Nuclear Fusion Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the Nuclear Fusion Market?

The nuclear medicine diagnostics market covered in this report is segmented –

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

What Regions Are Leading the Charge in the Nuclear Fusion Market?

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does the Definition of the Nuclear Fusion Market Include?

Nuclear medicine uses radioactive substances inside the body to diagnose illnesses or to target and remove diseased or damaged organs and tissue (for treatment). Nuclear medicine includes the use of radioactive drugs for research, therapeutic, and diagnostic purposes. Radioactive tracers are used in diagnostic nuclear medicine to visualize and/or measure the overall or local function of an organ.

Browse Through More Similar Reports By The Business Research Company:

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: